Generics company Actavis Inc. (NYSE:ACT) will acquire specialty pharma Warner Chilcott plc (NASDAQ:WCRX) in a stock deal that values Warner Chilcott at about $5 billion. Warner Chilcott shareholders will receive 0.16 Actavis shares …
WCRX) has received a distressing two-star ranking. With that in mind, let's take a closer look at Warner Chilcott's business and see what CAPS investors are saying about the stock right now. Sources: Capital IQ (a division of …
Warner Chilcott Plc (WCRX), whose stock is down 8 percent this year following last year’s 96 percent gain, is Molloy’s top pick, in part because it has massive cash flow. This marketer of women’s health and dermatology products recently …
Let’s see whether the stock can gather enough momentum to break through $13.10. ( click to enlarge ) WCRX broke out on huge volume. The stock closed up $1.30 today and looks poised to make another move on Tuesday. If WCRX
Warner Chilcott (Nasdaq:WCRX) hit a new 52-week low Monday as it is currently trading at $13.52, below its previous 52-week low of $13.63 with 1.4 million shares traded as of 1:56 p.m. ET. Average volume has been 2.7 million shares over …
Inc. ("WCRx"), both privately owned entities located in Scottsdale, Arizona, today announced CEO Todd Delano's direct management buyout of majority ownership of both companies' stock interest held by co-founder Dr. Randall S. Prust, …
In the report, Jefferies stated, "Our move is not tied to any fundamental change in our thesis, but rather stems from Actavis' (ACT, Hold) proposed $8.5B acquisition of WCRX announced last month. Since it is a stock-for-stock deal, WCRX
Specialty pharmaceutical company Actavis plc(ACT) Tuesday announced the completion of Warner Chilcott plc (WCRX) acquisition in a stock-for-stock transaction, valued at about $8.5 billion. The resultant combination will be a new …
Perhaps the biggest winner from last week’s Short Term Trading Strategies That Work: 7 Stocks You Need to Know …
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies ... http://investorplace.com/2012/11/3-pharmaceutical-stocks-to-sell-now-wcrx-shpg-sgnt/.